Clinical trial
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
NCT00357747 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00357747 |
|---|---|
| Title | AEG35156 and Docetaxel in Treating Patients With Solid Tumors |
| Official title | A Phase I Study of AEG35156 in Combination With Docetaxel in Patients With Solid Tumors |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | AEG35156, docetaxel |
| Enrollment | 10 |
| Start date | Jun 9, 2005 |
| Primary completion | Sep 26, 2006 |
| Completion | Jun 7, 2010 |
| First posted | Jul 27, 2006 |
| Last update posted | Aug 4, 2023 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: